CPT code 86870 represents an immunohematology laboratory procedure to identify specific antibodies directed against red blood cells in patient serum. This test is clinically important for transfusion safety, evaluation of hemolytic anemia, and peripartum antibody screening; it informs compatibility testing and clinical management decisions. Nationally, accurate coding and reporting of this laboratory service affect billing, quality measurement, and laboratory workflow.

Key payers typically involved in coverage and reimbursement discussions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose of CPT code 86870, common sites where the service is performed, and which payers are relevant for coverage considerations. The publication outlines benchmarks and reporting practices when available, summarizes policy implications for laboratory operations, and provides clinical context linking the assay to transfusion and hematology care pathways.

Data not available in the input for specific CPT-to-ICD-10 mappings, payer-specific fee schedules, and taxonomies. The content focuses on the code definition, clinical relevance, and the payer landscape at a national level.